人気の記事一覧

標的タンパク質分解誘導技術

Arvinas社の特許戦略(PROTAC)

Vepdegestrant(Arvinas&Pfizer)

¥100
9か月前

Expanding PROTACtable genome universe of E3 ligases

From classic medicinal chemistry to state-of-the-art interdisciplinary medicine: Recent advances in proteolysis-targeting chimeras technology